Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506869Aexternal-prioritypatent/GB8506869D0/en
Priority claimed from GB858511774Aexternal-prioritypatent/GB8511774D0/en
Priority claimed from US06/776,899external-prioritypatent/US4724232A/en
Priority claimed from GB858523881Aexternal-prioritypatent/GB8523881D0/en
Priority claimed from GB868603450Aexternal-prioritypatent/GB8603450D0/en
Priority claimed from AT0068386Aexternal-prioritypatent/AT390000B/de
Application filed by Wellcome FoundfiledCriticalWellcome Found
Priority to AT88987ApriorityCriticalpatent/AT392794B/de
Publication of ATA88987ApublicationCriticalpatent/ATA88987A/de
Application grantedgrantedCritical
Publication of AT392794BpublicationCriticalpatent/AT392794B/de
AT88987A1985-03-161987-04-09Verfahren zur herstellung von neuen pharmazeutisch annehmbaren estern und salzen von 3'-azido-3'-desoxythymidin
AT392794B
(de)
Verfahren zur herstellung von neuen psychogeriatrischen diazinylpiperidinderivaten von cyclischen amiden und imiden sowie von deren saeureadditionssalzen
Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptansubstituierten prostaglandinether- und -thioetheranalogen und von deren stereoisomeren und pharmazeutisch annehmbaren salzen
Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben